Serial monitoring of EGFR mutations in plasma and matched tissue from EGFR mutant non-small cell lung cancer patients on erlotinib

被引：0
|
作者：
Paweletz, Cloud P. [1 ]
Oxnard, Geoffrey R. [2 ]
Kuang, Yanan [1 ]
O'Connell, Allison [1 ]
Yanagita, Masahiko [2 ]
Messineo, Melissa M. [1 ]
Kirschmeier, Paul [1 ]
English, Jessie M. [1 ]
Jackman, David M. [2 ]
Jaenne, Pasi A. [2 ]
机构：
[1] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-939
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
939
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The efficacy of erlotinib for patients with non-small cell lung cancer with wild type of EGFR mutations
    Kobayashi, Takashi
    Koizumi, Tomonobu
    Tanabe, Tsuyoshi
    Tsushima, Kenji
    Urushihata, Kazuhisa
    Yamamoto, Hiroshi
    Hanaoka, Masayuki
    Kubo, Keishi
    Koyama, Shigeru
    Ooura, Nariaki
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S690 - S690
  • [2] EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) AND CORRELATION WITH SENSITIVITY TO ERLOTINIB
    Ricciardi, S.
    Tedesco, B.
    Migliorino, M. R.
    Graziano, P.
    Leone, A.
    Di Salvia, M.
    Capodaglio, V.
    Condo, S.
    De Santis, S.
    De Marinis, F.
    EJC SUPPLEMENTS, 2008, 6 (14): : 134 - 134
  • [3] EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non-Small Cell Lung Cancer Patients
    Yam, Irene
    Lam, David Chi-Leung
    Chan, Kaimin
    Ho, James Chung-Man
    Ip, Mary
    Lam, Wah-Kit
    Chan, Tai-Kwong
    Chan, Vivian
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1131 - 1140
  • [4] DETECTING EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hammoudeh, Z. A.
    Antonova, O.
    Staneva, R.
    Nikolova, D.
    Kyuchukov, Y.
    Penev, A.
    Mintchev, T.
    Koleva, V
    Hadjidekova, S.
    Toncheva, D.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2018, 21 (01) : 13 - 17
  • [5] CHARACTERISTICS OF EGFR MUTATIONS IN PLASMA SAMPLES FROM VIETNAMESE NON-SMALL CELL LUNG CANCER PATIENTS
    Thang Huu Nguyen
    Phuong Cam Pham
    Luyen Thi Le
    Loi Thuan Nguyen
    RESPIROLOGY, 2019, 24 : 113 - 113
  • [6] Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
    R. B. Verheijen
    T. T. van Duijl
    M. M. van den Heuvel
    D. Vessies
    M. Muller
    J. H. Beijnen
    J. M. Janssen
    J. H. M. Schellens
    N. Steeghs
    D. van den Broek
    A. D. R. Huitema
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 269 - 276
  • [7] Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
    Verheijen, R. B.
    van Duijl, T. T.
    van den Heuvel, M. M.
    Vessies, D.
    Muller, M.
    Beijnen, J. H.
    Janssen, J. M.
    Schellens, J. H. M.
    Steeghs, N.
    van den Broek, D.
    Huitema, A. D. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (02) : 269 - 276
  • [8] The presence of EGFR mutations predicts the response in Chinese non-small cell lung cancer patients treated with erlotinib
    Li, Rui-chao
    Zheng, Li-jun
    Fang, Ming-hao
    Yu, Shi-ying
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (02): : E112 - E119
  • [9] EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky
    Larson, Kara L.
    Huang, Bin
    Chen, Quan
    Tucker, Thomas
    Schuh, Marissa
    Arnold, Susanne M.
    Kolesar, Jill M.
    PLOS ONE, 2020, 15 (08):
  • [10] EGFR Genotype as a Predictor of Survival in EGFR Mutant Non-Small Cell Lung Cancer
    Syrigos, K.
    Tsagouli, S.
    Gkiozos, I.
    Paraskeva, M.
    Kotteas, I.
    Tsimpoukis, S.
    Zontanos, M.
    Grapsa, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S903 - S903
12345